4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-035040
Director sold 3,142 shares at an average $68.35 ($214,746)
- Director acquired 3,142 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Anderson Raymond · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,402 | $30.00 | $42,058 | 6,775 | D |
| 2026-11-02 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,740 | $30.00 | $52,200 | 8,515 | D |
| 2026-11-02 | Sale : show line 3 in the form 10b5-1 | −840 | $66.16 | $55,574 | 7,675 | D |
| 2026-11-02 | Sale : show line 4 in the form 10b5-1 | −600 | $67.06 | $40,236 | 7,075 | D |
| 2026-11-02 | Sale : show line 5 in the form 10b5-1 | −200 | $68.68 | $13,736 | 6,875 | D |
| 2026-11-02 | Sale : show line 6 in the form 10b5-1 | −1,502 | $70.04 | $105,200 | 5,373 | D |
| Open-market sales · 3,142 sh · avg $68.35 · $214,746 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −1,402 | 1,401 | D |
| 2026-11-02 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −1,740 | 1,740 | D |
Loading xslF345X06/rdgdoc.xml…